About the Myeloma Investment Fund (MIF)

The Myeloma Investment Fund (MIF) is a venture philanthropy fund that invests in promising companies, clinical assets, and technologies in oncology to drive the development of new therapies for multiple myeloma.

The MIF collaborates closely with portfolio companies to help them advance multiple myeloma research. This evergreen fund is supported entirely by philanthropy; all profits will be reinvested back into research for more effective treatments until there is a cure for every patient.

Learn more about The MIF

Line charts and bar graphs.Line charts and bar graphs.

About the Multiple Myeloma Research Foundation (MMRF)

The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives.

Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has raised over $600 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients.

Learn more about the MMRF

Couple hugging and smiling.

Contact Us

If you would like to contact The Myeloma Investment Fund, please use the email form below, call us at (203) 229 0464, or contact us by regular mail at the following address:

383 Main Avenue, 5th Floor
Norwalk, CT 06851

In order to submit the form please click, “I’m not a robot.”